首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1866564

生物晶片市場－2025-2030年預測

Biochips Market - Forecasts from 2025 to 2030

出版日期: 2025年11月07日 | 出版商:

Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計生物晶片市場將從 2025 年的 145.9 億美元成長到 2030 年的 262.92 億美元，複合年成長率為 12.50%。

生物晶片市場正經歷顯著成長，這主要得益於技術進步，使得在緊湊型微陣列平台上能夠進行快速並行的生物實驗。與電子晶片不同，生物晶片是一種非電子設備，其中包含數百萬個生物感測器，用於檢測酵素、蛋白質、DNA 和抗體等分析物。這些微反應器可應用於疾病診斷、藥物研發、基因組學、蛋白質組學和農業等領域，並具備追蹤、醫療感測（例如血壓、血糖值和血氧水平）和個人化醫療等特殊功能。由於危及生命的疾病發生率不斷上升、人口老化導致癌症等疾病風險增加，以及對個人化醫療解決方案的需求日益成長，預計到 2023 年及以後，該市場將持續成長。

關鍵成長要素包括全球醫療費用支出不斷成長以及政府對生技研發投入的增加。這些投資推動了生物晶片技術的進步，提高了其準確性和在各個領域的適用性。慢性病的快速成長以及對快速診斷的需求進一步推動了市場需求，尤其是對DNA晶片、蛋白質晶片和實驗室晶片系統的需求。生物技術公司、製藥公司、醫院、診斷中心和學術機構是主要的終端用戶，他們利用生物晶片進行創新研究和患者照護。然而，高成本、消費者認知度低以及對生物數據使用的隱私擔憂等挑戰制約著市場發展。持續的教育工作和強力的資料保護措施對於克服這些障礙和維持市場成長至關重要。

從區域來看，北美和歐洲憑藉其先進的醫療基礎設施和大規模研發投入，在市場主導。同時，亞太地區正經歷快速擴張，這得益於醫療費用支出的成長和慢性病的盛行率上升。隨著人們健康意識的提高和基礎建設的完善，中東和非洲以及南美洲也展現出新的發展潛力。區域法規結構影響市場動態，已開發市場嚴格的標準雖然確保了產品安全，但也增加了合規成本。

市場細分重點關注晶片類型（DNA晶片、蛋白質晶片、實驗室晶片等）、應用領域（藥物研發、疾病診斷、基因組學、蛋白質組學、農業等）以及最終用戶（生物技術/製藥公司、醫院、研究機構等）。競爭分析強調了主要參與者對創新的重視，近期達成的交易和投資增強了產品系列。各公司正優先發展先進的感測器技術和可擴展的生產能力，以滿足不斷成長的需求。基於產業報告和相關人員的市場洞察，運用包括生命週期分析和數據三角驗證在內的綜合調查方法預測市場趨勢。圖表等視覺化工具有助於相關人員更好地理解市場動態。

受技術進步、醫療需求成長和應用領域不斷拓展的推動，生物晶片市場預計將在2023年至2025年間實現強勁成長。解決成本壁壘、公眾認知不足和隱私顧慮等問題，對於充分發揮市場潛力至關重要，這將使生物晶片成為現代生物技術和個人化醫療的基石。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024 年）和預測資料（2025-2030 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

The biochips market is witnessing significant growth, driven by the technology's ability to perform rapid, simultaneous biological experiments on a compact microarray platform. Unlike electronic microchips, biochips are non-electronic devices equipped with millions of biosensors that detect analytes such as enzymes, proteins, DNA, or antibodies. These microreactors enable applications like disease diagnostics, drug discovery, genomics, proteomics, and agriculture, as well as specialized functions such as tracking, medical sensing (e.g., BP, glucose, oxygen), and personalized medicine. Since 2023, the market has been propelled by rising incidences of life-threatening disorders, an aging population susceptible to conditions like cancer, and increasing demand for tailored healthcare solutions.

Key growth drivers include expanding global healthcare expenditure and heightened government funding for biotechnology R&D. These investments support advancements in biochip technologies, enhancing their precision and applicability across diverse fields. The surge in chronic diseases and the need for rapid diagnostics further boost demand, particularly for DNA chips, protein chips, and lab-on-chip systems. Biotechnology and pharmaceutical companies, hospitals, diagnostic centers, and academic institutes are key end-users, leveraging biochips for innovative research and patient care. However, challenges such as high costs, limited consumer awareness, and privacy concerns related to biological data usage pose restraints. These hurdles necessitate ongoing education and robust data protection measures to sustain market growth.

Geographically, North America and Europe lead due to advanced healthcare infrastructures and significant R&D investments, while Asia-Pacific is experiencing rapid expansion driven by increasing healthcare spending and rising prevalence of chronic diseases. The Middle East, Africa, and South America show emerging potential as awareness and infrastructure develop. Regional regulatory frameworks influence market dynamics, with stringent standards in developed markets ensuring product safety but increasing compliance costs.

Market segmentation highlights types (DNA chips, protein chips, lab-on-chip, others), applications (drug discovery, disease diagnostics, genomics, proteomics, agriculture, others), and end-users (biotech/pharma, hospitals, research institutes, others). Competitive analysis underscores major players' focus on innovation, with recent deals and investments enhancing product portfolios. Companies are prioritizing advanced sensor technologies and scalable manufacturing to meet growing demand. Market insights, derived from industry reports and stakeholder inputs, utilize comprehensive methodologies, including lifecycle analysis and data triangulation, to forecast trends. Visual aids like charts enhance stakeholder understanding of market dynamics.

From 2023 to 2025, the biochips market is poised for robust growth, fueled by technological advancements, rising healthcare needs, and expanding applications. Addressing cost barriers, awareness gaps, and privacy concerns will be critical to unlocking the market's full potential, positioning biochips as a cornerstone of modern biotechnology and personalized medicine.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Type

DNA Chip
Protein Chip
Lab-on-Chip
Cell-Based & Tissue Chips

By Application

Drug Discovery and Development
Disease Diagnostics
Genomics
Proteomics
Agriculture
Environmental Testing
Others

By End-User

Biotech & Pharma
Hospitals & Diagnostics Centers
Academic & Research Institutes
CROs & Government Labs

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Italy
Others
Middle East & Africa
Saudi Arabia
UAE
Others
Asia Pacific
Japan
China
India
South Korea
Taiwan
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BIOCHIPS MARKET BY TYPE

5.1. Introduction
5.2. DNA Chip
5.3. Protein Chip
5.4. Lab-on-Chip
5.5. Cell-Based & Tissue Chips

6. BIOCHIPS MARKET BY APPLICATION

6.1. Introduction
6.2. Drug Discovery and Development
6.3. Disease Diagnostics
6.4. Genomics
6.5. Proteomics
6.6. Agriculture
6.7. Environmental Testing
6.8. Others

7. BIOCHIPS MARKET BY END-USER

7.1. Introduction
7.2. Biotech & Pharma
7.3. Hospitals & Diagnostics Centers
7.4. Academic & Research Institutes
7.5. CROs & Government Labs

8. BIOCHIPS MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Italy
- 8.4.5. Others
8.5. Middle East & Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Taiwan
- 8.6.6. Others